Cancer is second only to coronary artery disease, as being the most common cause of death. Progress in diagnosis and treatment 1ms had a significant effect on survival for some cancers, but the most common cancers such as lung and large bowel remain the most refractory. This study presents an effective cancer treatment via solar sonic electromagnetic chemical which is infusionably accessible and comprehensively coded for a variety of cancer conditions. All cancerous toxic components will undergo a form of physiological/ genetic/ reverse engineering. All potential pharmacological toxicity will be chemically reformulated and recondensed to specifically penetrate carcinogenic cells and lead to gradual eradication without affecting healthy cells, blood components or other internal organs. This invention relates to a medical device especially designed to treat cancer through a mechanism of promoting cytostasis, impairing mitosis, infusing cytochrome C-Protein and programming T-Lymphocyte/ T-Cells, as well as B-Lymphocyte/ B-Cells, thymus gland and inducing apoptosis all done simultaneously with a medicament selected from highly proprietary pharmaceutically infused therapeutic composition and immunotherapeutic agents, immunomodulators, and- antigenic agents, angiogenesis inhibitors, vascular sealing agents, gene-therapy agents, antibiotic resistant modification agents and a photodynamic therapy agents. The said medical device with all of its accompanying therapeutic infusion composition and other varied supporting capabilities can be used in oncology for the treatment of primary and metastatic tumors.Le cancer est la cause de décès la plus courante après les maladies coronariennes. Les progrès réalisés dans le diagnostic et le traitement ont un effet significatif sur la survie pour certains cancers, mais les cancers les plus courants tels que ceux du poumon et du côlon restent les plus réfractaires. Cette étude concerne un traitement efficace du cancer à laide dune substa
